Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients

Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients

Objective: Altered coagulation parameters in COVID-19 patients is associated with a poor prognosis. We tested whether COVID-19 patients on chronic oral anticoagulants (cOACs) for thromboembolism prophylaxis could receive protection from developing more severe phenotypes of the disease.Approach and R...

Full description

Bibliographic Details
Main Authors: Guido Iaccarino, Guido Grassi, Claudio Borghi, Davide Grassi, Costantino Mancusi, Maria Lorenza Muiesan, Massimo Salvetti, Massimo Volpe, Claudio Ferri
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
multimorbidity
atrial fibrillation
prophylaxis
death
intensive care admissions
COVID-19 outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.633878/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.633878/full

Similar Items